Treatment of Chronic Hepatitis C in a Patient Affected by Systemic Sclerosis

Table 3

Case reports from literature.

Age	Gender	IFN	Pathology	Dose	Duration	Timing of disease appearance	Therapy	Trend	Author, year and references
66	Female	INFαcon-1	Chronic viral hepatitis	18 MIU/daily for 2 weeks than 18 MIU/three times weekly	20 weeks	1 year after the end of IFN therapy	Tocopherol nicotinate	Partial relief with recurrent disease	Tahara et al. [5]
47	Female	INFα2b	Chronic viral hepatitis	3 MIU/three times weekly	Interrupted after 6 months	During therapy	Interruption of IFN therapy and prednisone 1 mg/kg/day	Limited form of systemic sclerosis	Solans et al. [3]
52	Female	INFα2a	Chronic myelogenous leukaemia	6 MIU/daily	25 months	During therapy	Loop diuretics, cyclophosphamide 100 mg/day, prostanoids, steroids	Partial improvement	Beretta et al. [4]